Introduction of sentinel lymph node biopsy, initially in clinically node-negative and
subsequently in patients presenting with involved axilla and downstaged by primary …

Background Primary chemotherapy in breast cancer poses a dilemma with regard to
adjuvant locoregional radiotherapy, as guidelines for locoregional radiotherapy were …

Historically, prognosis and treatment decision making for breast cancer patients have been
dictated by the anatomic extent of tumor spread. However, in recent years,“breast cancer” …

Triple-negative breast cancer (TNBC) is characterized by elevated locoregional recurrence
risk despite aggressive local therapies. New tumor-specific radiosensitizers are needed. We …

Background: Women with node-positive breast cancer are at high risk for recurrence. We
evaluate the impact of approximated tumor subtype and response to chemotherapy on long …

Purpose The extended role of breast-conserving surgery (BCS) in the neoadjuvant setting
may raise concerns on the oncologic safety of BCS compared to mastectomy. This study …

Background Neoadjuvant chemotherapy (NAC) is the standard approach for downstaging of
locally advanced breast cancer and can improve breast conservation rates. A pathological …

Background Data regarding axillary management after neoadjuvant endocrine therapy
(NET) are lacking. This study examined axillary management of hormone receptor-positive …

Background The expression of the immunoregulatory protein B7-H4 has been reported in
many types of cancer, including breast cancer. However, its role in triple-negative breast …

Aim This pooled analysis aimed to evaluate locoregional recurrence (LRR) rates of breast
cancer (BC) after neoadjuvant chemotherapy (NACT) and to identify independent LRR …